Filing Details

Accession Number:
0001567619-21-020599
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-16 18:47:44
Reporting Period:
2021-11-12
Accepted Time:
2021-11-16 18:47:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1770787 10X Genomics Inc. TXG () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1246406 Bradford Crutchfield C/O 10X Genomics, Inc.
6230 Stoneridge Mall Road
Pleasanton CA 94588
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-11-12 17,000 $1.16 60,336 No 4 M Direct
Class A Common Stock Disposition 2021-11-12 1,030 $163.10 59,306 No 4 S Direct
Class A Common Stock Disposition 2021-11-12 4,122 $164.18 55,184 No 4 S Direct
Class A Common Stock Disposition 2021-11-12 6,872 $164.87 48,312 No 4 S Direct
Class A Common Stock Disposition 2021-11-12 4,776 $165.89 43,536 No 4 S Direct
Class A Common Stock Disposition 2021-11-12 100 $167.27 43,436 No 4 S Direct
Class A Common Stock Disposition 2021-11-12 100 $168.34 43,336 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Stock Option (right to buy) Disposition 2021-11-12 17,000 $0.00 17,000 $1.16
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
443,000 2027-02-03 No 4 M Direct
Footnotes
  1. The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  2. This transaction was executed in multiple trades at prices ranging from $162.49 to $163.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  3. This transaction was executed in multiple trades at prices ranging from $163.50 to $164.495. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  4. This transaction was executed in multiple trades at prices ranging from $164.50 to $165.49. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  5. This transaction was executed in multiple trades at prices ranging from $165.51 to $166.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  6. This option, originally for 800,000 shares, of which 357,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.